Senseonics brings one-year Eversense 365 CGM to Beta Bionics iLet platform
Senseonics and Beta Bionics plan to integrate Eversense 365 with iLet, pairing one-year implantable CGM with automated insulin delivery.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Insulet expands Omnipod 5 to Spain, raising the stakes in Europe’s insulin pump market
Read how Insulet’s Omnipod 5 Spain launch could reshape tubeless insulin delivery, reimbursement and connected diabetes care.
Medical Devices & Diagnostics
Insulet’s next diabetes technology challenge is not control alone, it is usability at scale
Find out how Insulet’s Omnipod 6 and fully closed-loop data could reshape automated insulin delivery for diabetes care.
Medical Devices & Diagnostics
What Insulet’s EVOLUTION 2 data means for automated insulin delivery in type 2 diabetes
Insulet's EVOLUTION 2 study shows 68% TIR with no boluses in type 2 diabetes. Analysis of what the FCL data means before the EVOLVE pivotal trial.
Medical Devices & Diagnostics
Can Medtronic and Abbott redefine insulin delivery with the Instinct-integrated MiniMed 780G?
Medtronic’s MiniMed 780G now ships in the U.S. with Abbott’s Instinct sensor. Explore how this launch could reshape CGM-insulin system competition.